Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Expands By 15.9%

AstraZeneca PLC (OTCMKTS:AZNCF) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 67,800 shares, a growth of 15.9% from the March 15th total of 58,500 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is currently 20.5 days.

AstraZeneca Price Performance

Shares of OTCMKTS:AZNCF opened at $138.88 on Monday. The company’s 50 day simple moving average is $130.91 and its 200 day simple moving average is $130.68. AstraZeneca has a 1 year low of $118.16 and a 1 year high of $153.10.

AstraZeneca Increases Dividend

The firm also recently declared a dividend, which was paid on Monday, March 25th. Stockholders of record on Friday, February 23rd were issued a dividend of $1.97 per share. The ex-dividend date of this dividend was Wednesday, February 21st. This is a boost from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s payout ratio is 343.14%.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.